FDA panel gives nod to Merck's Vytorin – Cardiovascular Business
FDA panel gives nod to Merck's VytorinCardiovascular Business2 to recommend Merck's Vytorin (combination ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease. However, when it came to whether or not the approval s…